Enable Biosciences
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
510 Myrtle Ave Ste 101, South San Franci...Phone Number
(650) 240-3105Website
www.enablebiosciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Enable Biosciences
Enable Biosciences is a biotechnology company focused on developing advanced tools for predictive medicine, particularly in the area of type 1 diabetes. Founded in 2016 as a spin-off from UC Berkeley and Stanford, the company collaborates with prestigious institutions such as Stanford Healthcare and Harvard Medical School. They offer best-in-class autoantibody tests for type 1 diabetes and have performed over 150,000 tests to date. Their innovative technologies aim to enhance early detection and risk prediction for diabetes care.Explore more
Enable Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Enable Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Enable Biosciences has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Enable Biosciences
Earning: See what the market has to say on Enable Biosciences recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Enable Biosciences is spiking on competitors!
Funding: Get notified immidiatlly once Enable Biosciences has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Enable Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Enable Biosciences had a recent Job posting/layoffs
Product Launch: Get notified when Enable Biosciences launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Enable Biosciences
Compare insights from companies similar to Enable Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Enable Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Enable Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Enable Biosciences.
Enable Biosciences Tech Stack
A closer look at the technologies used by Enable Biosciences
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Sales, Safety, Public Health, Field /Outside Sales, Field Marketing, Health & Safety, Healthcare Operations, Operations, Patient Experience
Project
Product Management, Intellectual Property, Legal Affairs
Funding
Project
Spending/Investment
New Hire
Executive Move
Enable Biosciences News & Media
Advanced Screening Method for Early Detection of Type 1 Diabetes Exceeds Traditional Standards
SOUTH SAN FRANCISCO, Calif., May 15, 2024 /PRNewswire/ -- Researchers from Lund University and Enable Biosciences announced significant findings from their latest collaborative study, revealing the superior performance of the automated multiplex Antibody Detection by Agglutination-PCR...Enable Biosciences Appoints Will Robberts as Chief Financial Officer and Secures Strategic Funding
SOUTH SAN FRANCISCO, Calif., April 4, 2024 /PRNewswire/ -- Enable Biosciences Inc., a Stanford and UC Berkeley spinout company focusing on early disease detection today announced the appointment of Will Robberts as its new Chief Financial Officer (CFO) and the closing of an undisclosed...Enable Biosciences Publishes Study Revealing ADAP Technology's Improved Accuracy in T1D Risk Prediction
SOUTH SAN FRANCISCO, Calif., Feb. 13, 2024 /PRNewswire/ -- Enable Biosciences Inc. has shared compelling new data on the performance of its Antibody Detection by Agglutination-PCR (ADAP) technology in accurately predicting the risk of pre-symptomatic Type 1 Diabetes (T1D). Detailed...Enable Biosciences Enhances 'Kit to Clinics' with Rigorously Vetted ADAP Technology for Diabetes Care
SOUTH SAN FRANCISCO, Calif., Jan. 23, 2024 /PRNewswire/ -- Enable Biosciences Inc. is proud to announce the enhancement of its 'Kit to Clinics' program for type 1 diabetes care, featuring the ADAP (Antibody Detection by Agglutination-PCR) technology, rigorously and exhaustively vetted...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Enable Biosciences
Sign Up For FreeTo access detailed company insights
Enable Biosciences is a biotechnology company focused on developing advanced tools for predictive medicine, particularly in the area of type 1 diabetes. Founded in 2016 as a spin-off from UC Berkeley and Stanford, the company collaborates with prestigious institutions such as Stanford Healthcare and Harvard Medical School. They offer best-in-class... Read More
